Analyst Jackson holds a conference call with management on October 1 at 1 pm hosted by Benchmark.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUMA:
- Humacyte announces allowance of U.S. patent covering BioVascular Pancreas
- Humacyte initiated with a Buy at EF Hutton
- Hertz Global Holdings call volume above normal and directionally bullish
- Humacyte presents long-term results of ATEV in vascular trauma
- Small Cap Stocks: FDA Delay Created Buy-On-The-Dip Opportunity for Humacyte (HUMA)